HELEN HESLOP to Critical Pathways
This is a "connection" page, showing publications HELEN HESLOP has written about Critical Pathways.
Connection Strength
0.034
-
Clinical Utilization of Chimeric Antigen Receptor T Cells in B Cell Acute Lymphoblastic Leukemia: An Expert Opinion from the European Society for Blood and Marrow Transplantation and the American Society for Blood and Marrow Transplantation. Biol Blood Marrow Transplant. 2019 03; 25(3):e76-e85.
Score: 0.034